The collection draws together a selection of materials, including chapters from BSAVA Manuals, articles from Companion, webinars and Congress lectures.
The collection is divided into four areas: general information, client communication, client support and practitioner support. It includes things like:
Julian Hoad, Chair of the BSAVA Publications Committee said: “Death and taxes are the only two certainties of life, according to Benjamin Franklin! Our pets don’t have the worry of taxation but managing the end of life for them is something that all owners must face. It is probably the most challenging part of our veterinary work also – managing the emotional, sometimes highly charged, aspect of the situation, whilst maintaining an objective focus on the patient.
"This new collection provides a handy resource for this important area of veterinary practice. The collection will enable the recent graduate to gain confidence in dealing with these cases; tips for improvement that even the more experienced clinician will find useful are also included.”
The collection can be accessed via the BSAVA Library https://www.bsavalibrary.com/content/end-of-life---introduction at a cost of £20.00 for BSAVA members or £45.00 for non-members.
The first course will be overseen by Jodie Hughes, an RCVS and European specialist in anaesthesia and analgesia. The hospital’s inaugural resident will be Luisa Oliveira (pictured right), who earlier completed a rotating internship at North West Veterinary Specialists in Cheshire, and, more recently, an anaesthesia-specific one at NDSR.
Jodie said: “Luisa’s residency will comprise mainly the provision of anaesthesia to multiple animal species, ranging from the ‘simpler’ procedures to the most critical and complex, which we frequently encounter in our interventional cardiac procedures and emergency work.
“A significant component of the training will involve the management of pain, both in the acute setting (in the peri-operative period) and in the chronic setting, whilst dealing with our pain clinic patients.
“Luisa will also be trained in the management of emergency and critical care patients and will undergo rotations in other services to better grasp their requirements.
“As we work exclusively with dogs and cats, we will work in close collaboration with several other hospitals in the UK and continental Europe, to complement Luisa’s training with other species.
“As part of this, Luisa will be exposed to multiple advanced techniques, including ultrasound-guided regional nerve blocks and interventional procedures in our pain clinic.
Luisa said: “This is a fantastic opportunity for me to work alongside an incredibly experienced and skilled team at NDSR.
The training programme has been developed by Rui Pinelas, RCVS and European specialist in anaesthesia and analgesia at NDSR, who is optimistic there will be further training opportunities in the near future.
Rui said: “This was something NDSR has been keen to implement for some time and we had been having ongoing discussions to choose the perfect time.
“In terms of logistics, it took around three months for us to set up this anaesthesia residency, which was largely spent organising our partnerships with the other training facilities and undergoing an evaluation as to whether our facilities and case load would meet the specialist board’s strict requirements, which we are delighted they did.”
The Legislative Reform Consultation took place between November 2020 and April 2021 and asked members of the veterinary profession and the public to give their responses to a package of proposals for future veterinary legislation designed to enhance the role of veterinary nurses, modernise RCVS registration, lead to a modern fitness to practise regime, and ensure the regulation of veterinary practices.
The proposals represent the biggest legislative reform since the 1966 Veterinary Surgeons Act.
In total the consultation received 1,330 responses, of which 714 (54%) were from veterinary surgeons, 335 (25%) from veterinary nurses, 93 (7%) from veterinary paraprofessionals, 73 (5%) from student veterinary nurses, 58 (4%) from members of the public, 40 (3%) from veterinary and industry organisations, including representative bodies, and the remainder from veterinary students and veterinary practice managers.
An analysis of the consultation responses covering each of the five core areas and their individual recommendations can be found in the final report, which is available at www.rcvs.org.uk/legislativereform.
After considering this report, Council voted by a majority to accept the recommendations, meaning that they are now formally adopted as RCVS policy and will form the basis for discussions on the need for new legislation with the Department for Environment, Food & Rural Affairs (Defra).
Professor Stephen May has chaired the Legislation Working Party that developed the proposal since its inception in 2017 when he was RCVS President. He said: “We are very grateful to those individuals and organisations who took the time to complete this very important consultation on recommendations for the future legislative framework for the professions. We also appreciate the candour of those who were unsure about or opposed to the recommendations.
“When the Legislation Working Party met to consider the responses and the report, it decided that, while no substantive changes needed to be made to the principle-based recommendations, the points raised both against and in favour of individual recommendations gave us important material for additional consideration, and food for thought as to how any detailed proposals would be implemented once enabling legislation is in place.
“We look forward to submitting these recommendations to Defra formally, with a view to them becoming, in time, a bill put before Parliament to replace the Veterinary Surgeons Act 1966. In so doing, this would establish a modern, flexible and comprehensive piece of legislation that would make sure the regulatory structure for the veterinary professions is fit for purpose for decades to come.”
As well as the main report of the Legislative Reform Consultation, RCVS Council also considered a series of interim measures that would be in line with the overall aims of future legislative changes, but which could be implemented without primary legislation.
The proposed interim measures included:
Council members voted on each of these interim measures on an individual basis – with the mini-PICs and the Charter Case Protocol being accepted by majority vote.
However, Council members voted against implementing the change to the standard of proof at this time, citing a number of concerns about the potential impact of it being implemented under the current concerns investigation and disciplinary procedures. Similar concerns had been put forward by many of those who responded to the consultation itself.
Eleanor Ferguson, RCVS Registrar, said: “The approved procedural changes will, I believe, lead to a significant improvement in the efficiency and effectiveness of our disciplinary processes. The Charter Case Protocol will mean that, in suitable cases where a finding of serious professional misconduct at a full disciplinary hearing would likely only lead to a reprimand or to no further action being taken, a more proportionate and less time-consuming and expensive means of resolving cases will be available. However, it will still reflect the seriousness of the matters and continue to protect the public interest, welfare and the reputation of the profession.
“Furthermore, by phasing out the Case Examiner Group stage and instead referring concerns to ‘mini’ PICs, which will decide if the threshold of serious professional misconduct has been met, it will make our concerns investigation processes clearer and more streamlined and therefore more efficient. We look forward to publishing further details on both of these changes in due course.
“Although Council members accepted that a change of the standard of proof would be an integral part of introducing a modern fitness to practise (FTP) regime as part of any future legislation, they had significant concerns about the ‘interim’ recommendation to introduce it under the current arrangements, in advance of implementing a full FTP model, and so a majority felt that they could not vote for it.”
To read the full report of the Legislative Reform Consultation, including analysis of the responses, please visit www.rcvs.org.uk/legislativereform.
The Suresign range consists of:
Shane Brewer, Veterinary Business Development Manager at CIGA Healthcare, said: "We are very excited to be branching out into the veterinary field with our very affordable veterinary rapid tests. With the recent increase in pet ownership over the previous year, it is important to offer vets and their clients an affordable alternative to the tests they are currently using."
Ciga says its tests are easy to perform and interpret, competitively priced and offer results in 5-10 minutes.
For more information (in due course), visit: www.suresignveterinary.com
CVS says the new hospital, which will be based at Central Park, Avonmouth, will be custom-built with uniquely designed facilities, state-of-the-art diagnostic tools such as MRI and CT scanners, and a cutting-edge stereotactic linear accelerator for radiotherapy in cancer treatment, the only one of its kind for pets in England.
The hospital, which will open next summer, will employ over 100 people led by a team of Specialist veterinary surgeons and supported by residents, interns and registered veterinary nurses.
Planning permission has been granted for the project, and CVS is now appointing building contractors.
Richard Fairman, CEO of CVS Group, said: "We are extremely excited to be developing this innovative new specialist veterinary hospital in Bristol, providing the best animal care to pet owners across the South West. With state-of-the-art equipment and some of the highest qualified veterinary professionals, we are confident that the site will act as a centre of excellence in the veterinary world, and be a leader in Europe for cancer treatments.
"The new hospital signals our commitment to investing in cutting-edge technology to bring cancer treatment in pets to the next level. It will provide a number of employment opportunities and secure specialist veterinary skills in the Bristol area. We look forward to finalising development plans and opening the doors to pet owners in 2022."
The study1 was led by the RVC’s VetCompass Programme and is the largest study using anonymised veterinary health records to explore dry eye in dogs. The study included 363,898 dogs that were followed for a year to identify 1,456 dogs affected with dry eye.
The study found that one in every 250 dogs overall is affected by the condition, but certain breeds are especially prone.
The worst affected breeds were: American Cocker Spaniel (5.90%), West Highland White Terrier (2.21%), Cavalier King Charles Spaniel (1.91), Lhasa Apso (1.86%), English Bulldog (1.82%), English Bull Terrier (1.65%,) and English Cocker Spaniel (1.60%).
Other findings included:
The authors of the study have recommended that vets help reduce the frequency and impact of KCS by testing for the adequacy of tear production as part of the annual physical examination of all dogs but especially for the list of predisposed breeds as they approach advanced age.
Dr Dan O’Neill, Senior Lecturer, Companion Animal Epidemiology, at the RVC, and author of the paper, said: "We all love those glossy puppy dog eyes, but this study shows that sadly not every dog enjoys good eye health. This research identifies that flattened faces in some breeds makes these breeds more prone to this painful dry eye condition. Work is urgently going on to improve the health of many of these flat-faced breeds, but in the meantime the message from everyone who cares about dogs is to ‘stop and think before buying a flat-faced dog."
Rick Sanchez, European Specialist in Veterinary Ophthalmology says: "Taking a fresh dip into an old, dull looking disease like KCS has shown us there is more for us to learn than we thought. Ultimately, all of us, clinicians, nurses, researchers, breeders and dog owners are, in one form or another, care givers for our beloved animals. All of us need whatever new information we can set our eyes on to inform our next steps in improving canine ocular health. There’s no better eye opener than evidence-based scientific findings. I hope this research helps all of us raise awareness about canine KCS and that it helps us keep those animal eyes looking fresh and healthy, as they should.”
Bill Lambert, Health, Welfare and Breeder Services Executive at The Kennel Club commented: "These findings are important to help us to identify which dogs are most at risk of developing dry eye. Ultimately, this should help owners that may need support in spotting the initial signs, as well as ways to treat affected dogs and how to prevent it occurring in the future. The data from this fascinating research will also be used to collaboratively create strategies to tackle health priorities with the breed clubs of affected breeds."
Reference
Photo: Cavalier King Charles Spaniel with KCS. By Rick F Sanchez BSciBiol DVM DipECVO CertVetEd FHEA.JPG
The new course will be led by Dr Pedro Malho, DipECVO CES OphtVet DVM MRCVS, a European and RCVS Recognised Specialist in Veterinary Ophthalmology. It is built around 14 modules covering the embryology, anatomy and physiology of the eye, ocular pharmacology and therapeutics, together with the full spectrum of ocular diseases seen in domestic species.
Modules are delivered using a range of learning techniques, including interactive online lessons supported by notes and videos, quizzes and a forum tutored by leading specialists.
Pedro said: “We have prepared an innovative and in-depth course to help veterinary practitioners with an interest in ophthalmology to develop their knowledge and skills in this demanding discipline. The course will enable delegates to develop a greater knowledge of ocular anatomy and physiology and master the handling of ophthalmic equipment.
“It will also help them to interpret clinical signs confidently to make a diagnosis and select the appropriate medical or surgical treatment.”
Dr Charlotte French (pictured right) from Improve, said: “With input from top global veterinary ophthalmologists, we have created an exciting and innovative learning experience that will offer maximum flexibility to veterinary surgeons keen to develop their expertise and knowledge in this field. The programme provides delegates with unique features such as the opportunity to share learning with colleagues from around the world and input from an Improve International Programme Tutor to support their studies.”
The programme, which has been submitted to RACE for approval, can also be undertaken as a face-to-face course. It offers a route to achieve academic qualifications - the General Practitioner Certificate (GPCert) awarded by ISVPS and the Postgraduate Certificate (PgC), awarded by Harper Adams University. Gaining a PgC enables delegates to apply to the RCVS for Advanced Practitioner Status in the subject.
For further information and to register, visit: https://www.improveinternational.com/uk/course/pgc-gpcert-small-animal-ophthalmology-distance-learning
Ian (pictured right) qualified from Glasgow University and has a master’s degree in veterinary parasitology. He is head of ESCCAP - the European Scientific Counsel Companion Animal Parasites (ESCCAP) UK and Ireland, guideline director for ESCCAP Europe and editorial board member for Companion Animal. and VetCPD Journal. He is also a practising vet and co-owner of The Mount Veterinary Practice in Fleetwood, Lancashire.
Lockdown has seen a rise in the numbers of dogs and cats in the UK, including imported pets. Horiba says some of these are coming in via the official route, which includes preventative measures to reduce health risks. However, many are moved outside of UK regulations and some will become ill in the days or even months after they arrive. Ian will explain how timely, accurate testing will help detect the threat to these animals.
Lisa Martin from Horiba said: "I hope that as many veterinary surgeons, nurses, students and support staff as possible will join us for our Educational Premiere! We are looking forward to this first webinar in our veterinary CPD series, with expert Ian Wright highlighting the best ways to keep pets and people safe. Join us on 1st July at 7.30pm to hear more and to ask Ian your questions on this very topical subject. Dress code: casual."
To register, visit: https://attendee.gotowebinar.com/register/5429203015286962191
322 farmers took part in the survey, 83% of which had a flock of over 100 ewes.
Three quarters of them had experienced abortions in their ewes during both the 2018/2019 and 2019/2020 lambing seasons. Of those that experienced abortions during the 2019/2020 lambing season, a quarter reported that the problem occurred in more than 2% of their flock and 44% of them did not ask their vet to investigate.
Katherine Timms, Ceva Animal Health’s ruminant veterinary advisor said: “Farmers who decide not to investigate why their ewes are aborting may well experience an abortion storm during the following year’s lambing season as Chlamydophila abortus, the bacteria that causes EAE, has the ability to lay latent in ewes until the next pregnancy.
“This means that one infected sheep shedding at lambing has the potential to infect multiple ewes that will almost certainly abort at their next lambing. The consequences can be financially and reproductively devastating for farmers and it’s advisable that vets raise awareness of EAE testing with their clients to help prevent this from happening. Ceva’s Assure Ewe programme offers farmers subsidised farm serology testing for Chlamydia abortus. Aborted ewes can be tested for Chlamydia abortus, ideally from three weeks to three months after lambing.”
Of the 47% of farmers that are not vaccinating against EAE, 57% said they would consider it. Reasons not to vaccinate included farmers believing that they had closed flocks (59%) and EAE not having been diagnosed (57%). Only 20% decided not to vaccinate because of cost and 25% because they did not feel it was worthwhile.
Ceva is continuing its ‘For Flock’s Sake – Vaccinate!’ initiative during 2021 to help raise awareness of EAE and highlight the importance of vaccination. This year, Ceva is also highlighting the importance of testing aborted ewes through its ‘For Flock’s Sake Get Tested’ campaign which encourages the submission of samples to a diagnostic laboratory or blood sampling after lambing has finished.
For more information, visit www.enzooticabortion.co.uk, contact your Ceva Animal Health account manager, call Ceva on 01494 781510 or email cevauk@ceva.com.
Photo: Ewe ewe looking at?
The ERP was established in 2016 when it emerged that an increasing number of research projects were being conducted in private veterinary practices. In these settings, researchers may not always be familiar with the regulations and the ethical best practice needed for clinical veterinary research.
The ERP reviews both prospective and retrospective research projects on cats, dogs, horses and farm animals. As well as reviewing animal-based research, the panel also reviews sociological studies involving veterinary staff.
There are currently seven available spaces on the panel, and the RCVS is looking to fill the spaces with:
The Panel is Chaired by Professor David Morton, who said: “I’ve been honoured to Chair the Ethics Review Panel for the last five years. Through my role as Chair, I have had the opportunity to work alongside some exceptional veterinary professionals and I encourage anyone with a keen interest in clinical veterinary research to apply for a position on the Panel.”
To apply, visit www.rcvs.org.uk/ethics-panel and send a completed application form and CV to ethics@rcvs.org.uk.
The deadline for applications is 5pm on Friday 16 July 2021.
Based at UCLan’s Preston Campus, the new school will deliver foundation, undergraduate and postgraduate courses in areas such as veterinary medicine, bioveterinary science, veterinary clinical practice, veterinary physiotherapy and rehabilitation, and clinical animal behaviour and training.
Professor Graham Baldwin, UCLan Vice-Chancellor, said: “We’re absolutely delighted to be creating an innovative and dynamic veterinary school. UK veterinary schools are highly prestigious, so we are thrilled to be launching only the second school in the north of England and one of only 11 in the UK.
“We have taken massive strides in developing all areas of human health provision in recent years, and animal health will now join our ever-expanding portfolio of medicine, dentistry, pharmacy, biomedical sciences and optometry.”
Professor Cathy Jackson, Executive Dean of the Faculty of Clinical and Biomedical Sciences, said: “Our new veterinary school will be focussed on producing much needed industry ready graduates for our region, particularly as recent figures have highlighted a national shortage of vets and a sector heavily reliant on vets educated in the European Union.
"As with our medical and dental schools, we have demonstrated we want to break down barriers and make education accessible to all. It’s no different with our veterinary school and we want to open the doors and offer a pathway for any student, no matter of their background, into this rewarding profession, while maintaining the very highest of education and professional standards.”
The Batchelor of Veterinary Medicine and Surgery (BVMS) course at UCLan is a five-year programme with ‘hands-on’ modules from Year 1, rather than in the later years as delivered in more traditional programmes.
UCLan says it is collaborating with Myerscough College for some of its programmes to give students access to state-of-the-art, sector-leading facilities, which have recently benefited from a £35m investment.
In addition, UCLan will become one of the first universities in the world to make use of a digital, virtual dissection platform for teaching animal anatomy using veterinary Anatomage technology.
UCLan is planning to welcome the first intake of UK and international students to veterinary sciences BSc and foundation courses in September 2022 while BVMS students will be welcomed from 2023.
For more information, visit www.uclan.ac.uk/schools/veterinary-medicine.
The role was created last November when the Animal & Plant Health Agency (APHA) started allowing para-professional staff to support vets in carrying out TB testing in England.
UK Farmcare says there are now 49 fully authorised ATTs in England with another 21 TB testing under veterinary supervision and three undergoing the theory part of the training.
To become an ATT, applicants must be at least 18 years old, hold a valid UK driving licence and passport, possess a clean criminal record and then be approved by the APHA. Applicants also need at least three graded GCSEs or equivalent in English, Maths and a science or food production subject and at least six months cattle handling experience.
https://ukfarmcare.com/an-introduction-to-the-att-role.
The company says that Daxocox achieves significant improvement of clinical signs associated with the pain of osteoarthritis (OA) in dogs1,2 and also helps reduce the risk of breakthrough pain.
Breakthrough pain is defined as “an abrupt, short-lived, and intense pain that breaks through the analgesia that controls pain”3. Risk factors for breakthrough pain in cases of canine OA include poor owner compliance, variable plasma drug levels between doses, natural or exercise induced flare-ups and disease progression.
According to research carried out by the company, veterinary surgeons estimate that nearly half of their canine OA cases on daily NSAIDs experience breakthrough pain4, whilst owners put the figure much higher at 80%5.
Animalcare says that as well as compromising patient welfare and increasing the risk of clinical consequences such as wind-up pain (hypersensitisation), breakthrough pain risks owners losing confidence in their vet and/or the recommended treatment plan for their dog. This may lead owners to independently stray from the treatment plan, with potentially damaging consequences. In its research, 87% of vets agreed that avoiding breakthrough pain is critical to the management of canine OA4.
Animalcare adds that because of the pharmacology, there is no risk of risk of over-accumulation or need for mandatory treatment ‘breaks’6. Also, adverse effects were found to be no different from any other NSAID1,2 and there was no increase in treatment-related adverse effects at up to 5 times the recommended dose7, so Daxocox has a broad margin of safety and is well tolerated by dogs7.
James Beaumont, marketing manager at Animalcare said: “Daxocox’s weekly administration of a flavoured tablet addresses some of the challenges of managing canine OA that I’m certain most vets will identify with. Breakthrough pain is a real problem and by being able to provide consistent pain control, in a compliance friendly formulation, Daxocox is a real game changer for canine OA management.
For more information, visit: www.animalcare.co.uk, or contact your local Animalcare territory manager, or Animalcare’s head office on 01904 487687.
References:
The new Mars Equestrian Veterinary Research Scholar Programme offers the opportunity to conduct research alongside some internationally-renowned experts in equine health and veterinary welfare while pursuing two advanced credentials: the Graduate Certificate in Animal Welfare and Behavior at Penn Vet during year one, followed by the Master of Research (MRes) program at the RVC in year two.
The RVC says the new format offers an exclusive opportunity for the candidate to refine their critical research skills and expand animal welfare knowledge while learning on location at both the RVC in England and Penn Vet’s New Bolton Center in Kennett Square, Pennsylvania, United States.
The RVC’s MRes programme gives students the chance to develop into scientists who can work well across interdisciplinary teams, tackling problems of practical relevance to veterinary and medical science. Many of the courses’ graduates go on to work in some of the world’s leading scientific research institutes, as well as within industry and government.
Professor Richard Bomphrey, Interim Vice Principal for Research at the RVC said: “I am delighted that the RVC is able to support this new transatlantic initiative for veterinary graduates following a generous donation from Mars Equestrian. It strengthens the ties between the RVC, the University of Pennsylvania and Mars Equestrian while providing an outstanding training and research opportunity. We look forward to welcoming the successful scholar and helping them to make an impact in equine research."
The Veterinary Research Scholar program is open to interested UK, US and international candidates holding a veterinary degree (DVM/VMD/BVSc or equivalent). The chosen candidate will receive an annual stipend and tuition as well as travel expenses.
The programme will commence in September 2021 in the United States before moving to the UK in October 2022 until its conclusion in September 2023.
The deadline to submit applications for consideration is 30th June 2021 or until an acceptable candidate is identified.
Applications should be sent to the Penn Vet’s Dr. Kyla Ortved atkortved@vet.upenn.edu.
Ms Benson faced six charges.
The first was that between January 2018 and November 2019 she took a number of bags of dog food and two horse wormer syringes from the practice without paying for them.
Charge 2 alleged that between November 2018 and November 2019 she took a number of items of animal food and one or more boxes of horse wormer and paid less than the correct amount for them.
Charge 3 was that between October 2018 and November 2019 she arranged for or allowed a friend to receive a discount on items from the practice, without consent from the practice.
Charge 4 alleged that in December 2019 she asked a veterinary surgeon colleague to input details of treatment and/or medicine for her cat into the clinical records of another of her animals that was also registered to the practice.
Charge 5 was that in relation to charges 1, 2 and 3, her conduct was dishonest.
Charge 6 alleged that in relation to charge 4, her conduct was dishonest, potentially compromised the integrity of a professional colleague and was potentially detrimental to animal welfare.
At the outset of the hearing, Ms Benson admitted to charges 1,2,3,4 and 6 of the allegations and the Committee accepted these admissions. The Committee considered evidence from Ms Benson’s colleagues including witness statements, written testimonial and clinical records for her animals.
When asked about taking items from the practice, Ms Benson explained that she did not intend to take items without paying for them and that she had not realised how much she had taken. She also explained that she had paid back in full what she owed to the practice. The Committee considered that Ms Benson’s conduct had involved a degree of premeditation as she had repeatedly taken items over an extended period. They also considered that there had been a potential risk of injury to animals resulting from Ms Benson’s request to incorrectly write up her animal’s veterinary records.
The defence attested that no actual harm had come to any animal because of Ms Benson’s actions and that she previously had an unblemished career in veterinary nursing. She had also admitted most of the charges against her and paid for the items she had taken in full.
Cerys Jones, chairing the Committee and speaking on its behalf, said: “The Committee considered that in the case of Ms Benson, there had been a potential risk to animals had her pet’s records been incorrectly completed, although no harm resulted. The request to alter the records had been a short, single event, but the taking of items had been repeated over a period.
"The Committee also considered that Ms Benson had abused the trust placed in her as a senior nurse with managerial responsibility. We took into account that there was some evidence of Ms Benson being overloaded by work, but there was no evidence of any health condition during the time of the misconduct which might explain her actions.”
The Committee therefore found Ms Benson guilty of serious professional misconduct and decided that a nine-month suspension from the Register was the most appropriate sanction.
Cerys Jones said: “The Committee accepted that Ms Benson had developing insight in making her admissions and we give her credit for her long unblemished career. She admitted to a large part of the allegation, expressed remorse for her actions and has repaid the practice. We have also heard a number of positive testimonials which spoke positively of Ms Benson’s recent conduct.
“However, dishonesty is a serious matter in relation to professional practice and taking no action in response to the serious nature of Ms Benson’s disgraceful conduct would not be proportionate or serve to protect animals and maintain public confidence in the profession.
“Having carefully considered matters, the Committee decided that the appropriate and proportionate sanction, was to suspend Ms Benson’s registration for nine months.”
Ms Benson has 28 days from being informed of the outcome of the hearing to appeal the Committee’s decision.
Swindon-based Eastcott Veterinary Referrals is looking for a new resident to join its dentistry team.
Eastcott’s dentistry department is led by Andrew Perry, an EBVS European Veterinary Specialist in Dentistry. He's supported by Peter Southerden, AVDC Founding Fellow in Oral and Maxillofacial Surgery – one of only 14 founding fellows in the world and the only one practicing in Europe.
The residency programme will offer an in-depth knowledge in veterinary dentistry through a mix of clinical and non-clinical work.
It will also provide an opportunity to work alongside world class surgeons responsible for some of the most advanced dental surgical procedures of today.
The clinical aspect of the role will require the candidate to manage cases and perform all forms of dental and oral surgical procedures and client communication, with guidance from senior staff.
The role will also involve preparation of scientific articles for publication and will help develop the candidate's teaching and presenting skills and externships in diagnostic imaging, surgery and anaesthesia.
Andrew said: “The team at Eastcott are proud to be a part of developing future specialists in a discipline that is growing rapidly and has such an impact on patient welfare.
“Our multidisciplinary approach to management of dental, oral and maxillofacial pathologies means that the successful candidate will have the benefit of exposure to a very diverse, and at times cutting edge, caseload.
“The residency programme is well-established at Eastcott. The dentistry, oral and maxillofacial team, the hospital directors and the Linnaeus central support team are committed to individual development and growth and work hard to provide an environment and support to allow our residents to flourish.”
For more information on this role, visit www.eastcottreferrals.co.uk or email andrew.perry@eastcottvets.co.uk before July 31.
CardioCare is based on research carried out at the Purina Technology Center which explored how nutrients can support the ailing heart. First, a series of metabolomics studies identified metabolic changes that occur in MMVD. Then the company developed a ‘Cardiac Nutritional Blend’ to address these metabolic changes and evaluated it in a clinical study.
The main elements of the Cardiac Nutritional Blend include carnitine precursors, antioxidants and medium-chain triglycerides. Purina says the latter provides an alternative energy source that is easy for the struggling heart to use, something which is particularly important as the metabolomics research revealed that dogs with MMVD showed less efficient cardiac energy metabolism1.
The company highlights a 2019 clinical study, which showed that the Cardiac Nutritional Blend has the potential to delay disease progression in dogs with preclinical MMVD. Over the six-month study period, dogs with preclinical MMVD fed the Cardiac Nutritional Blend showed a reduction in left atrial size, while an equivalent group of dogs fed a control diet showed an increase. Additionally, none of the dogs fed the Cardiac Nutritional Blend progressed from stage B1 to B2 during the study, while 37% of dogs fed the control diet showed progression2.
Purina also says that while the research to date has focused on MMVD, the nutrients in CardioCare are recognised to be beneficial under conditions of cardiac stress and the diet may prove a useful tool to provide support in a wider range of conditions. The company recommends that the diet be considered as part of the management plan for any dog with cardiac insufficiency.
Dr Libby Sheridan, Purina Scientific Affairs Manager for the UK & Ireland, said: "Metabolomics research has the scope to drive huge advances in managing a range of conditions. We’re proud to be at the forefront of this exciting field and bring the benefits of our findings to vets in practice.
"CardioCare opens up a new avenue of support for patients with cardiac insufficiency and vets can use this diet as a tool to complement medical treatment."
CardioCare will be available from 30th June. Contact vettechline@purina.nestle.com for more information.
References
Presenters at the webinar will include: Professor Melissa McDermid MD, MPH, division head, Occupational & Environmental Medicine, University of Maryland, Prof. Clare Knottenbelt BVSC MSC DSAM MRCVS, owner and founder of specialist referral service, Hawk and Dove, and previously clinical director of the Small Animal Hospital at the University of Glasgow Veterinary School, Sam Fontaine MSc, lecturer and director of the MSc Advanced Practice in Veterinary Nursing and module leader within the BVMS programme at The Glasgow School of Veterinary Medicine. There will also be a video from the oncology centre at The Queen’s Veterinary School, Cambridge University.
The webinar will also look at the use of Closed System Transfer Devices, such as Tevadaptor, to improve safety and break down barriers to treatment across all practices.
Clare Knottenbelt (pictured right) said: “Pets with cancer need to be able to access chemotherapy treatments locally. The advent of new closed administration systems mean that practices can now safely administer chemotherapeutics in house without the need for large investment, but still protecting the health of their staff."
Delegates will be able to to submit questions to the speakers and will receive a certificate for one hour of CPD. The session will be recorded so it can be watched again.
For the full programme or to register, visit: https://aesculap-academia.eventbritestudio.com/160802290981
The programme starts in January 2022 and places are on a first come, first served basis.
The BSAVA says the new programme is designed primarily for veterinary surgeons working in small animal practice who have a particular interest in diagnostic imaging. The aim is to provide participants with the knowledge and expertise they need to choose the most clinically relevant diagnostic imaging technique confidently and competently.
Participants will also learn how to interpret images obtained with radiography and ultrasonography accurately and enhance their understanding of more advanced imaging techniques.
The programme is designed to allow part time study and comprises 75% core teaching with a 25% elective component, allowing participants to personalise their study to meet their clinical needs. The in-person attendance part of the programme focuses on hands on practicals and workshops.
The online units for the programme will contain both pre-recorded webinars as well as interactive live sessions with the unit teachers. Students can also choose one of the two currently available electives to focus on at the end of the second year: either ‘Enhanced Ultrasonography’ or ‘Enhanced Cardiac Imaging’.
Lucie Goodwin, Head of Education said: “The certificate has been designed to take into account the caseload and facilities in primary care practice ensuring that it is relevant, and the skills students learn can be directly applied to practice. An increased amount of content delivered online means that the certificate is more accessible to vets around the UK and overseas, minimising travelling for attendance days, which are mainly for practical sessions. We are also pleased to be able to offer an elective component to this PGCert and following feedback from students, will look to develop further electives.”
The programme will be assessed by written exams, a case diary and a case book. Successful completion will lead to the award of BSAVA Postgraduate Certificate in Small Animal Diagnostic Imaging (BSAVA PGCertSADI).
To apply, visit the BSAVA website here. If you have any questions about the certificate, you can contact certificate@bsava.com.
The oral corticosteroid powder formulation was previously only available in 180g tubs.
Severe equine asthma, which was previously known as Recurrent Airway Obstruction (RAO), Chronic Obstructive Pulmonary Disease (COPD) or Heaves, can lead to airway neutrophil influx and excessive mucus production. Although it is generally managed by environmental measures to suppose triggering factors, it can be combined with corticosteroid therapy to control airway inflammation in more severe cases.
Alana McGlade BVMedSci BVM BVS MRCVS, Equine Business Manager, said: "Severe equine asthma is the most common cause of chronic coughing in mature horses. Attributed to a hypersensitivity to inhaled allergens and dust, clinical signs - such as inflammation of the airways - can be alleviated by Equisolon’s active ingredient prednisolone.
"Prednisolone has been shown to have positive effects on clinical signs, endoscopic evaluation, arterial blood gases and pulmonary function when used in conjunction with environmental changes to reduce a horse’s exposure to potential triggers.
"Previously, vets would have had to measure out the powder but the sachets make dosing more convenient. The sachets come in a box of 10, so each pack will treat one 300 kg horse for 10 days or one 600 kg horse for 5 days. As the sachets are pre-measured, horses get exactly the dose they need.”
Equisolon oral powder contains 33.3 mg/g of prednisolone and should be administered at 1 mg prednisolone per kg of body weight per day. Treatment can be repeated at 24 hour intervals during 10 consecutive days.
For more information visit www.dechra.co.uk
Cancer Care for Pets offers both clinical and palliative care for pets with cancer, supporting the work of the first opinion team at Donaldson's and taking referral cases from far and wide.
Neil and Kirsty have worked in practice together in the Yorkshire area for seven years, working with owners and families to create treatment plans involving diagnostic investigations, specialised imaging, surgery, chemotherapy and palliative care.
Neil said: "As far as we know, we are one of very few services to offer this combination of veterinary and nurse-led consultations, where comprehensive cancer treatment and care plans are developed together with owners. We have worked hard to instil our team approach where, following surgery and treatment, the Cancer Care team, the owner and the referring practice are all involved in the pet’s ongoing care and wellbeing."
Kirsty said: “Neil and I do many of our consults together. Neil will give his clinical overview and I will help owners to process and understand the treatment and the next steps for their pet.
“It was incredibly important to us to create a friendly, welcoming environment in our new dedicated consultation area at the hospital. We need people to trust us and be honest about how fit and well their pet really is, in the knowledge we are not automatically going to tell them there is nothing we can offer them. Treating cancer is about life, not managing a death, and making sure that the pet’s life – even if it is limited – is as good as it can be.”
Neil said: "The Cancer Care for Pets team will be working alongside the wider Donaldson’s veterinary and nursing teams and we are keen to learn from each other. The facilities at the hospital are second to none, particularly our new purpose-built consultation area, the practice’s new CT scanner and the high spec operating facilities. Donaldson’s also has a well-respected rehabilitation and pain clinician with whom we can work closely to help our older patients to keep mobile, flexible and maintain activity levels.”
Neil and Kirsty are supported by a third member of the Cancer Care for Pets team, oncology nurse Jenna Carrick RVN.
Cancer Care for Pets is now accepting referrals. Contact: info@cancercareforpets.co.uk or 01484 242911.
2021’s event will see over 70 hours of CPD across eight themes, with speakers including Megan Brashear and Helen Wilson, clinical lead for ECC at Langford Vets, University of Bristol.
RCVS President Mandisa Greene will open Congress with reflections from the past year. She'll be followed by the keynote speaker, Marie Holowaychuk, who will be sharing her knowledge and experience around health and wellbeing.
Dan Lewis – ECC specialist at Vets Now, who planned the veterinary Congress programme, said: “In 2020, the world of live events changed, and in November we delivered our first ECC virtual Congress to great success.
"Not only do we feel it is the right decision for everyone to continue our ECC Congress as a virtual event, but the format brings a huge number of opportunities for delegates, exhibitors and speakers, who joined us from all across the world.
"The interactive platform we’re using is cutting edge and it provides so much more than just webinars. Like last year, there will be live content, an interactive exhibition hall and more opportunities than ever for delegates to network and learn from some of the world’s leading veterinary experts discussing emergency and critical care.
"Our programme again this year has been carefully tailored to provide an inclusive learning experience for vets and vet nurses no matter what stage they’re at in their career, from students through to specialists.
"All being well, we will be back in Leeds for the ECC Congress in November 2022.” Full four-day tickets for delegates will range in price from £60 to £199 and ticket-holders will be able to access all the sessions on-demand for up to a month following the event.
To book your ticket, visit congress.vets-now.com
Dr Henry faced one charge, that in January 2020 she wrote and/or signed an undated letter confirming that a ewe had died in transit to the surgery due to dystocia and peri-parturient stress, when in fact she had euthanised the animal at the veterinary practice the day before. The letter, which was addressed 'To whom it may concern’, was on practice letterheaded paper and signed "Louise Henry MRCVS".
The second part of the charge outlined that her conduct concerning the letter was dishonest.
The Committee heard that the ewe was lambing and brought to the practice by a client. Dr Henry was on-call at the time and advised a Caesarean section. The client agreed and Dr Henry delivered two live lambs and one dead lamb.
Dr Henry was concerned about the welfare of the ewe post-surgery because of the risk of peritonitis and advised that the ewe should be euthanised.
The client agreed to the ewe being euthanised and then asked Dr Henry to write a letter in which it was stated that the ewe had died in transit on route to the practice. Dr Henry agreed to write the letter in which she falsely certified that the ewe had died in transit.
The letter came to light when the practice director found it in an insurance file. The practice arranged an investigatory meeting with Dr Henry where she admitted that writing the letter was an error of judgement. When asked about her conduct, Dr Henry explained that the client had subsequently been dissatisfied with the letter she had written and asked her to change it. She refused to amend the letter and told him that it was wrong of her to have written it in the first place and that she regretted having done so.
Dr Henry told the Committee that she valued integrity very highly and that she was deeply ashamed that she had been prepared to write the dishonest letter.
The Committee heard several testimonials from people who had worked with or studied alongside Dr Henry, who all attested to her skill as a veterinary surgeon and that they had no concerns about her integrity and honesty. She self-reported her actions from January to the RCVS and from the outset admitted the facts of the charge. During the hearing, Dr Henry submitted that her action of dishonest false certification amounted to disgraceful conduct in a professional respect.
Dr Martin Whiting, chairing the Committee, and speaking on its behalf, said: “The Committee considered that, in this case, the aggravating features were limited and the mitigating factors extensive. There was no premeditated dishonesty or financial gain involved, there was no actual harm or risk of harm to an animal or human and this was a single incident in an otherwise unblemished 13-year career. The Committee found that the shame and remorse expressed by Dr Henry were entirely genuine. Her conduct on this occasion was entirely untypical of her practise.
“After careful consideration, the Committee concluded that the substantial mitigating features permitted it to take the somewhat unusual course of issuing a reprimand in a case involving dishonesty. In taking this course, the Committee attached significant weight not only to the isolated nature of the event but also to the genuine insight shown by Dr Henry and the lasting impact this event has had upon her. In the Committee’s assessment, a reasonable and fully informed member of the public would, in this particular case, regard a reprimand as a sanction which protected the public interest in the profession and upheld its standards.”
The full documentation for the hearing can be found at www.rcvs.org.uk/disciplinary
The company says Locox TT has been developed to have high levels of EPA and DHA Omega-3, with independent lab analysis showing it contains over four times more Omega-3s than the market leading supplement.
The new product also chondroprotective ingredients and antioxidants.
Locox TT comes in tablet form: 1-2 tabs per day, with no loading phase required.
Will Peel, TVM UK’s product manager said: "Locox TT has undergone extensive independent testing so vets can be assured that the information they give to pet owners is verified and can be trusted.
"With an abundance of joint supplements on the market, we believe it is important that vets are able to make informed decisions when selecting their chosen brand, by providing clear, trustworthy information, alongside a high-quality product.’
TVM says it will be making client leaflets and waiting room questionnaires to help pet owners identify the symptoms of osteoarthritis in dogs.
For more information, visit www.tvm-uk.com/locoxtt or contact your local TVM territory manager.
The company points to research which found that 89% of the veterinary profession wants to play a more active role in the sustainability agenda1.
For that reason, Boehringer says it put sustainability at the heart of Aservo EquiHaler, which uses no propellant gasses and the container for which is made from up to 50% recycled materials.
Now Boehringer has launched the first recycling programme for a prescription medicine in the UK to support the responsible disposal of the Aservo EquiHaler.
To join the programme, you need to visit: https://equihaler.uk/recycling, set up a TerraCycle account and register your practice. Boehringer says it only takes 10 minutes.
Once signed-up, a Boehringer Ingelheim Territory Manager will arrange for a collection box to be delivered, along with supporting practice display posters. When the box is full, there is a free pick-up service.
Practices that sign-up for the programme before 31st July 2021 will be entered into a prize draw, with the chance to win a year’s supply of ethically-sourced chocolate for their practice.
Reference: